Telus 2027 Outlook Murky Despite Credible 2028 De-Leveraging Plan

Dow Jones11-10

1432 ET - RBC thinks the new management of Telus is "likely to stick the 2028 landing," but until then, analyst Drew McReynolds says he's staying on the sidelines "pending better visibility on the 2027 outlook," and better entry points. Longer term, McReynolds expects management to deliver on its 2028 de-levering target 3.0x while generating free cash flow at a compounded annual growth rate of above 10%. To fund this turnaround, Telus is rolling out a C$900 million efficiency program and shedding non-core assets, with the sale process of its first Telus Health business at an "advanced stage."

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment